Postmarketing Surveillance Study of Atrovent® Inhalets in Chronic Obstructive Airways Disease

NCT02238132 · clinicaltrials.gov ↗

COMPLETED

Status

374

Enrollment

INDUSTRY

Sponsor class

Conditions

Pulmonary Disease, Chronic Obstructive

Interventions

DRUG: ATROVENT® inhalets

Sponsor

Boehringer Ingelheim